References
Sutor AH. Vitamin K deficiency bleeding in infants and children. Semin Thromb Hemost 1995; 21(3): 317–29
McNinch AW, Upton C, Samuels M, et al. Plasma concentrations after oral or intramuscular vitamin K1 in neonates. Arch Dis Child 1985; 60(9): 814–8
von Kries R. Oral versus intramuscular Phytomenadione: safety and efficacy compared. Drug Saf 1999 Jul; 21(1): 1–6
Which vitamin K preparation for the newborn? Drug Ther Bull 1998 Mar; 36(3): 17–9
Greer FR, Marshall SP, Foley AL, et al. Improving the vitamin K status of breastfeeding infants with maternal vitamin K supplements. Pediatrics 1997 Jan; 99(1): 88–92
von Kries R, Hanawa Y. Neonatal vitamin K prophylaxis. Report of Scientific and Standardization Subcommittee on Perinatal Haemostasis. Thromb Haemost 1993; 69(3): 293–5
McNinch AW, Tripp JH. Haemorrhagic disease of the newborn in the British Isles: two year prospective study. BMJ 1991; 303(6810): 1105–9
von Kries R, Gobel U. Vitamin K prophylaxis and vitamin K deficiency bleeding (VKDB) in early infancy. Acta Paediatr 1992; 81(9): 655–7
Ekelund H. Late haemorrhagic disease in Sweden 1987–1988. Acta Paediatr Scand 1991; 80(10): 966–8
Tönz O, Schubiger G. Neonatale vitamin K prophylaxe und vitamin-K-Mangelblutungen in der Schweiz 1986–1988. Schweiz Med Wochenschr 1988; 118: 1747–52
Parker L, Cole M, Craft AW, et al. Neonatal vitamin K administration and childhood cancer in the north of England: retrospective case-control study. BMJ 1998; 316(7126): 189–93
Dargaville PA, Campbell NT. Overdose of ergometrine in the newborn infant: acute symptomatology and long-term outcome. J Paediatr Child Health 1998; 34(1): 83–9
Golding J, Paterson M, Kinlen LJ. Factors associated with childhood cancer in a national cohort study. Br J Cancer 1990; 62: 304–8
Golding J, Greenwood R, Birmingham K, et al. Childhood cancer, intramuscular vitamin K, and pethidine given during labour. BMJ 1992; 305(6849): 341–6
McKinney PA, Juszczak E, Findlay E, et al. Case-control study of childhood leukaemia and cancer in Scotland: findings for neonatal intramuscular vitamin K. BMJ 1998; 316(7126): 173–7
Passmore SJ, Draper G, Brownbill P, et al. Ecological studies of relation between hospital policies on neonatal vitamin K administration and subsequent occurrence of childhood cancer. BMJ 1998; 316(7126): 184–9
Passmore SJ, Draper G, Brownbill P, et al. Case-control studies of relation between childhood cancer and neonatal vitamin K administration. BMJ 1998; 316(7126): 178–84
Rights and permissions
About this article
Cite this article
Oral or IM phytomenadione for neonates? The debate continues. Drugs Ther. Perspect 14, 14–16 (1999). https://doi.org/10.2165/00042310-199914090-00005
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-199914090-00005